Age-specific survival

Cancer

Cancer	Years	Method	Sex	Age	Survived	Net survival	95% lower	95% upper
Hodgkin	2004-2008	cohort	Female	15-44	1.00 years	98.6%	96.6%	100.0%
Hodgkin	2004-2008	cohort	Female	15-44	5.00 years	95.1%	91.6%	98.8%
Hodgkin	2004-2008	cohort	Female	15-44	10.00 years	93.5%	89.3%	97.9%
Hodgkin	2004-2008	cohort	Female	45-54	1.00 years	100.0%	0.0%	0.0%
Hodgkin	2004-2008	cohort	Female	45-54	5.00 years	82.1%	63.0%	100.0%
Hodgkin	2004-2008	cohort	Female	45-54	10.00 years	82.1%	63.0%	100.0%
Hodgkin	2004-2008	cohort	Female	55-64	1.00 years	84.4%	71.4%	99.8%
Hodgkin	2004-2008	cohort	Female	55-64	5.00 years	76.8%	61.9%	95.2%
Hodgkin	2004-2008	cohort	Female	55-64	10.00 years	61.7%	41.2%	92.2%
Hodgkin	2004-2008	cohort	Female	65-74	1.00 years	84.5%	70.7%	100.0%
Hodgkin	2004-2008	cohort	Female	65-74	5.00 years	60.1%	42.0%	86.2%
Hodgkin	2004-2008	cohort	Female	65-74	10.00 years	41.1%	23.0%	73.4%
Hodgkin	2004-2008	cohort	Female	75-99	1.00 years	50.4%	33.9%	74.8%
Hodgkin	2004-2008	cohort	Female	75-99	5.00 years	38.5%	20.8%	71.2%
Hodgkin	2004-2008	cohort	Female	75-99	10.00 years	26.3%	10.3%	67.2%

[3]

[4]